drugset / Trial / NCT00182364

PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT Pilot)

NCT00182364

RandomizedParallel-groupDouble-blindPrevention

Summary

PROTECT Pilot objective is to assess: 1) the feasibility of timely enrollment and complete, blinded study drug administration, 2) the bioaccumulation of LMWH in patients with acquired renal insufficiency and its association with bleeding, 3) the feasibility of scheduled twice weekly lower limb ultrasounds, and 4) recruitment rates for a future randomized trial.

Timeline

Start
2003-02
Primary completion
Completion
2004-02

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Dalteparin sodium Other / unclassified 5000 iu Subcutaneous
Subject Heparin Other / unclassified 5000 iu Subcutaneous